早期连续肾脏替代疗法对败血症相关急性肾损伤患者的影响:MIMIC-IV 数据库分析。

IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Yongseop Lee, Jun Hye Seo, Jaeeun Seong, Sang Min Ahn, Min Han, Jung Ah Lee, Jung Ho Kim, Jin Young Ahn, Su Jin Jeong, Jun Yong Choi, Joon-Sup Yeom, Hyung Jung Oh, Nam Su Ku
{"title":"早期连续肾脏替代疗法对败血症相关急性肾损伤患者的影响:MIMIC-IV 数据库分析。","authors":"Yongseop Lee, Jun Hye Seo, Jaeeun Seong, Sang Min Ahn, Min Han, Jung Ah Lee, Jung Ho Kim, Jin Young Ahn, Su Jin Jeong, Jun Yong Choi, Joon-Sup Yeom, Hyung Jung Oh, Nam Su Ku","doi":"10.3346/jkms.2024.39.e276","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Renal replacement therapy (RRT) is an important treatment option for sepsis-associated acute kidney injury (AKI); however, the optimal timing for its initiation remains controversial. Herein, we investigated the clinical outcomes of early continuous kidney replacement therapy (CKRT), defined as CKRT initiation within 6 hours of sepsis-associated AKI onset, which was earlier than the initiation time defined in previous studies.</p><p><strong>Methods: </strong>We used clinical data sourced from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. This study included patients aged ≥ 18 years who met the sepsis diagnostic criteria and received CKRT because of stage 2 or 3 AKI. Early and late CKRTs were defined as CKRT initiation within 6 hours and after 6 hours of the development of sepsis-associated AKI, respectively.</p><p><strong>Results: </strong>Of the 33,236 patients diagnosed with sepsis, 553 underwent CKRT for sepsis-associated AKI. After excluding cases of early mortality and patients with a dialysis history, 45 and 334 patients were included in the early and late CKRT groups, respectively. After propensity score matching, the 28-day mortality rate was significantly lower in the early CKRT group than in the late CKRT group (26.7% vs. 43.9%, <i>P</i> = 0.035). The early CKRT group also had a significantly greater number of days free of mechanical ventilation (median, 19; interquartile range [IQR], 3-25) and vasopressor administration (median, 21; IQR, 5-26) than the late CKRT group did (median, 10.5; IQR, 0-23; <i>P</i> = 0.037 and median, 13.5; IQR, 0-25; <i>P</i> = 0.028, respectively). The Kaplan-Meier curve also showed that early CKRT initiation was associated with an improved 28-day mortality rate (log-rank test, <i>P</i> = 0.040). In contrast, there was no significant difference in the 28-day mortality between patients who started CKRT within 12 hours and those who did not (log-rank test, <i>P</i> = 0.237).</p><p><strong>Conclusion: </strong>Early CKRT initiation improved the survival of patients with sepsis-associated AKI. Initiation of CKRT should be considered as early as possible after sepsis-associated AKI onset, preferably within 6 hours.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 43","pages":"e276"},"PeriodicalIF":3.0000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11557250/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact of Early Continuous Kidney Replacement Therapy in Patients With Sepsis-Associated Acute Kidney Injury: An Analysis of the MIMIC-IV Database.\",\"authors\":\"Yongseop Lee, Jun Hye Seo, Jaeeun Seong, Sang Min Ahn, Min Han, Jung Ah Lee, Jung Ho Kim, Jin Young Ahn, Su Jin Jeong, Jun Yong Choi, Joon-Sup Yeom, Hyung Jung Oh, Nam Su Ku\",\"doi\":\"10.3346/jkms.2024.39.e276\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Renal replacement therapy (RRT) is an important treatment option for sepsis-associated acute kidney injury (AKI); however, the optimal timing for its initiation remains controversial. Herein, we investigated the clinical outcomes of early continuous kidney replacement therapy (CKRT), defined as CKRT initiation within 6 hours of sepsis-associated AKI onset, which was earlier than the initiation time defined in previous studies.</p><p><strong>Methods: </strong>We used clinical data sourced from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. This study included patients aged ≥ 18 years who met the sepsis diagnostic criteria and received CKRT because of stage 2 or 3 AKI. Early and late CKRTs were defined as CKRT initiation within 6 hours and after 6 hours of the development of sepsis-associated AKI, respectively.</p><p><strong>Results: </strong>Of the 33,236 patients diagnosed with sepsis, 553 underwent CKRT for sepsis-associated AKI. After excluding cases of early mortality and patients with a dialysis history, 45 and 334 patients were included in the early and late CKRT groups, respectively. After propensity score matching, the 28-day mortality rate was significantly lower in the early CKRT group than in the late CKRT group (26.7% vs. 43.9%, <i>P</i> = 0.035). The early CKRT group also had a significantly greater number of days free of mechanical ventilation (median, 19; interquartile range [IQR], 3-25) and vasopressor administration (median, 21; IQR, 5-26) than the late CKRT group did (median, 10.5; IQR, 0-23; <i>P</i> = 0.037 and median, 13.5; IQR, 0-25; <i>P</i> = 0.028, respectively). The Kaplan-Meier curve also showed that early CKRT initiation was associated with an improved 28-day mortality rate (log-rank test, <i>P</i> = 0.040). In contrast, there was no significant difference in the 28-day mortality between patients who started CKRT within 12 hours and those who did not (log-rank test, <i>P</i> = 0.237).</p><p><strong>Conclusion: </strong>Early CKRT initiation improved the survival of patients with sepsis-associated AKI. Initiation of CKRT should be considered as early as possible after sepsis-associated AKI onset, preferably within 6 hours.</p>\",\"PeriodicalId\":16249,\"journal\":{\"name\":\"Journal of Korean Medical Science\",\"volume\":\"39 43\",\"pages\":\"e276\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-11-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11557250/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Korean Medical Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3346/jkms.2024.39.e276\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Korean Medical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3346/jkms.2024.39.e276","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:肾脏替代疗法(RRT)是脓毒症相关急性肾损伤(AKI)的重要治疗选择;然而,启动该疗法的最佳时机仍存在争议。在此,我们研究了早期持续肾脏替代治疗(CKRT)的临床效果,CKRT 的定义是在脓毒症相关急性肾损伤发生后 6 小时内启动,这比以往研究中定义的启动时间要早:我们使用的临床数据来自重症监护医学信息市场 IV(MIMIC-IV)数据库。本研究纳入了年龄≥ 18 岁、符合脓毒症诊断标准并因 2 期或 3 期 AKI 而接受 CKRT 的患者。早期和晚期 CKRT 的定义分别为脓毒症相关性 AKI 发生后 6 小时内和 6 小时后开始的 CKRT:在 33,236 名确诊为脓毒症的患者中,553 人因脓毒症相关性 AKI 而接受了 CKRT。在排除早期死亡病例和有透析史的患者后,早期和晚期 CKRT 组分别有 45 名和 334 名患者。经过倾向评分匹配后,早期 CKRT 组的 28 天死亡率明显低于晚期 CKRT 组(26.7% 对 43.9%,P = 0.035)。早期 CKRT 组无需机械通气的天数(中位数,19 天;四分位数间距 [IQR],3-25 天)和无需使用血管加压剂的天数(中位数,21 天;四分位数间距 [IQR],5-26 天)也明显多于晚期 CKRT 组(分别为中位数,10.5 天;四分位数间距 [IQR],0-23 天;P = 0.037 和中位数,13.5 天;四分位数间距 [IQR],0-25 天;P = 0.028)。Kaplan-Meier 曲线还显示,早期开始 CKRT 与 28 天死亡率的改善有关(对数秩检验,P = 0.040)。相比之下,在12小时内开始接受CKRT治疗的患者与未在12小时内开始接受CKRT治疗的患者的28天死亡率没有明显差异(对数秩检验,P = 0.237):结论:早期启动 CKRT 可提高脓毒症相关性 AKI 患者的生存率。脓毒症相关性 AKI 发病后应尽早考虑启动 CKRT,最好在 6 小时内启动。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact of Early Continuous Kidney Replacement Therapy in Patients With Sepsis-Associated Acute Kidney Injury: An Analysis of the MIMIC-IV Database.

Background: Renal replacement therapy (RRT) is an important treatment option for sepsis-associated acute kidney injury (AKI); however, the optimal timing for its initiation remains controversial. Herein, we investigated the clinical outcomes of early continuous kidney replacement therapy (CKRT), defined as CKRT initiation within 6 hours of sepsis-associated AKI onset, which was earlier than the initiation time defined in previous studies.

Methods: We used clinical data sourced from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. This study included patients aged ≥ 18 years who met the sepsis diagnostic criteria and received CKRT because of stage 2 or 3 AKI. Early and late CKRTs were defined as CKRT initiation within 6 hours and after 6 hours of the development of sepsis-associated AKI, respectively.

Results: Of the 33,236 patients diagnosed with sepsis, 553 underwent CKRT for sepsis-associated AKI. After excluding cases of early mortality and patients with a dialysis history, 45 and 334 patients were included in the early and late CKRT groups, respectively. After propensity score matching, the 28-day mortality rate was significantly lower in the early CKRT group than in the late CKRT group (26.7% vs. 43.9%, P = 0.035). The early CKRT group also had a significantly greater number of days free of mechanical ventilation (median, 19; interquartile range [IQR], 3-25) and vasopressor administration (median, 21; IQR, 5-26) than the late CKRT group did (median, 10.5; IQR, 0-23; P = 0.037 and median, 13.5; IQR, 0-25; P = 0.028, respectively). The Kaplan-Meier curve also showed that early CKRT initiation was associated with an improved 28-day mortality rate (log-rank test, P = 0.040). In contrast, there was no significant difference in the 28-day mortality between patients who started CKRT within 12 hours and those who did not (log-rank test, P = 0.237).

Conclusion: Early CKRT initiation improved the survival of patients with sepsis-associated AKI. Initiation of CKRT should be considered as early as possible after sepsis-associated AKI onset, preferably within 6 hours.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Korean Medical Science
Journal of Korean Medical Science 医学-医学:内科
CiteScore
7.80
自引率
8.90%
发文量
320
审稿时长
3-6 weeks
期刊介绍: The Journal of Korean Medical Science (JKMS) is an international, peer-reviewed Open Access journal of medicine published weekly in English. The Journal’s publisher is the Korean Academy of Medical Sciences (KAMS), Korean Medical Association (KMA). JKMS aims to publish evidence-based, scientific research articles from various disciplines of the medical sciences. The Journal welcomes articles of general interest to medical researchers especially when they contain original information. Articles on the clinical evaluation of drugs and other therapies, epidemiologic studies of the general population, studies on pathogenic organisms and toxic materials, and the toxicities and adverse effects of therapeutics are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信